Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDemyelinating diseases of the central nervous systemICD-10-CM g37-other-demyelinating-diseases
    Ask Trek AI about this page

    ICD-10-CM Code For Other Demyelinating Diseases Of Central Nervous System: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group G37 includes demyelinating diseases of the central nervous system that are not classified elsewhere, such as acute disseminated encephalomyelitis and other specified demyelinating disorders affecting the brain, spinal cord, or optic nerves. These ICD-10-CM diagnosis codes are used to document clinical presentations of central nervous system demyelination, capturing disease distribution, severity, and any associated neurologic deficits. Accurate coding within the ICD-10-CM G37 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Other Demyelinating Diseases Of Central Nervous System: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM G37: Other Demyelinating Diseases Of Central Nervous System Overview

    This group includes demyelinating conditions affecting the central nervous system beyond multiple sclerosis and related disorders, targeting the brain, spinal cord, and optic pathways. Accurate coding captures the specific demyelinating diagnosis, anatomical involvement, and disease complexity, which informs clinical records and supports appropriate reimbursement. Clear documentation of neurologic signs, imaging, and course is important for correct code selection.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when clinical documentation indicates a demyelinating disease of the central nervous system that does not meet criteria for multiple sclerosis or other specified categories. Select the most specific code based on documented diagnosis, anatomical involvement, and clinical course.

    ICD-10-CM Codes

    9 rows

    ICD-10-CM CodeDescription
    G37.0Diffuse sclerosis of central nervous system
    G37.1Central demyelination of corpus callosum
    G37.2Central pontine myelinolysis
    G37.3Acute transverse myelitis in demyelinating disease of central nervous system
    G37.4Subacute necrotizing myelitis of central nervous system
    G37.5Concentric sclerosis [Balo] of central nervous system
    G37.81Myelin oligodendrocyte glycoprotein antibody disease
    G37.89Other specified demyelinating diseases of central nervous system
    G37.9Demyelinating disease of central nervous system, unspecified

    DRG Codes

    11 rows

    DRG CodeDescription
    023Craniotomy with Major Device Implant or Acute Complex CNS Principal Diagnosis with MCC or Antineoplastic Implant or Epilepsy with Neurostimulator
    024Craniotomy with Major Device Implant or Acute Complex CNS Principal Diagnosis without MCC
    058Multiple Sclerosis and Cerebellar Ataxia with MCC
    059Multiple Sclerosis and Cerebellar Ataxia with CC
    060Multiple Sclerosis and Cerebellar Ataxia without CC/MCC
    097Non-Bacterial Infection of Nervous System Except Viral Meningitis with MCC
    098Non-Bacterial Infection of Nervous System Except Viral Meningitis with CC
    099Non-Bacterial Infection of Nervous System Except Viral Meningitis without CC/MCC
    974HIV with Major Related Condition with MCC
    975HIV with Major Related Condition with CC
    976HIV with Major Related Condition without CC/MCC

    Typical Clinical Scenarios

    • A middle-aged adult presents to the emergency department with acute onset of unilateral optic neuritis characterized by painful eye movement and subacute vision loss over several days. Neuro-ophthalmologic exam shows decreased visual acuity and a relative afferent pupillary defect; MRI brain and orbit reveal an enhancing optic nerve lesion without widespread brain plaques, prompting a diagnosis within this demyelinating group for isolated optic nerve inflammation. Typical codes: G37.0
    • A young adult with relapsing-remitting neurological symptoms (intermittent paresthesias, motor weakness, and balance problems) undergoing outpatient neurology follow-up for a chronic demyelinating disorder that does not meet full criteria for multiple sclerosis; clinical course and imaging indicate a chronic central nervous system demyelinating disease requiring long-term management. Typical codes: G37.2, G37.81
    • An older patient hospitalized for acute new focal neurological deficits after a recent viral illness, where evaluation shows progressive central demyelination attributed to an inflammatory myelopathy rather than ischemic stroke; inpatient workup excludes other causes and a demyelinating diagnosis is recorded as the reason for admission and treatment. Typical codes: G37.3, G37.89

    Related Codes

    G35-MULTIPLE-SCLEROSIS

    ICD-10-CM Code For Multiple Sclerosis: Group Overview

    G36-OTHER-ACUTE-DISSEMINATED-DEMYELINATION

    ICD-10-CM Code For Other Acute Disseminated Demyelination: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.